147 related articles for article (PubMed ID: 38588692)
41. Additional more factors should be included in predicting risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Liu Y; Mo Y; Wu A
J Viral Hepat; 2021 Mar; 28(3):573. PubMed ID: 33264447
[No Abstract] [Full Text] [Related]
42. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis B virus and hepatocellular carcinoma.
Bruix J; Llovet JM
J Hepatol; 2003; 39 Suppl 1():S59-63. PubMed ID: 14708679
[No Abstract] [Full Text] [Related]
44. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem.
Boora S; Sharma V; Kaushik S; Bhupatiraju AV; Singh S; Kaushik S
Braz J Microbiol; 2023 Jun; 54(2):679-689. PubMed ID: 37059940
[TBL] [Abstract][Full Text] [Related]
45. Reply to 'Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B'-A reply.
Liu Y
J Viral Hepat; 2021 Oct; 28(10):1502. PubMed ID: 34216526
[No Abstract] [Full Text] [Related]
46. Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden.
Singh SP; Mondia N
Hepatol Commun; 2022 Dec; 6(12):3592. PubMed ID: 35811444
[No Abstract] [Full Text] [Related]
47. Reply to 'Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B'.
Kamalapirat T; Ungtrakul T
J Viral Hepat; 2021 Oct; 28(10):1501. PubMed ID: 34219333
[No Abstract] [Full Text] [Related]
48. Consider more about risk scores for predicting hepatocellular carcinoma in patients with chronic hepatitis B.
Liu Y
J Viral Hepat; 2021 Oct; 28(10):1500. PubMed ID: 34216528
[No Abstract] [Full Text] [Related]
49. Curbing the liver cancer epidemic in Africa.
Hainaut P; Boyle P
Lancet; 2008 Feb; 371(9610):367-8. PubMed ID: 18242399
[No Abstract] [Full Text] [Related]
50. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
[TBL] [Abstract][Full Text] [Related]
51. Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B.
Huang R; Zhang Z; Wang J; Zhang S; Wu C
Aliment Pharmacol Ther; 2023 Nov; 58(9):965-966. PubMed ID: 37831536
[No Abstract] [Full Text] [Related]
52. Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B.
Zhao J
Aliment Pharmacol Ther; 2023 Nov; 58(9):964. PubMed ID: 37831535
[No Abstract] [Full Text] [Related]
53. Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis.
Zeng G; Gill US; Kennedy PTF
Gut; 2020 Nov; 69(11):1907-1912. PubMed ID: 32451325
[No Abstract] [Full Text] [Related]
54. HLA-DP gene polymorphisms and hepatitis B infection in the Japanese population.
Migita K; Abiru S; Ohtani M; Jiuchi Y; Maeda Y; Bae SK; Bekki S; Hashimoto S; Yesmembetov K; Nagaoka S; Nakamura M; Komori A; Ichikawa T; Nakao K; Yatsuhashi H; Ishibashi H; Yasunami M
Transl Res; 2012 Dec; 160(6):443-4. PubMed ID: 22749777
[No Abstract] [Full Text] [Related]
55. The Changing Global Epidemiology of Hepatocellular Carcinoma.
Caines A; Selim R; Salgia R
Clin Liver Dis; 2020 Nov; 24(4):535-547. PubMed ID: 33012444
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis B Virus-related Care Quality in Patients With Hepatitis B/Human Immunodeficiency Virus Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study.
Lee TH; Hunt CM; Maier MM; Lowy E; Beste LA
Clin Infect Dis; 2022 Oct; 75(9):1529-1536. PubMed ID: 35349635
[TBL] [Abstract][Full Text] [Related]
57. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China.
Song P; Feng X; Zhang K; Song T; Ma K; Kokudo N; Dong J; Yao L; Tang W
Biosci Trends; 2013 Feb; 7(1):1-6. PubMed ID: 23524887
[TBL] [Abstract][Full Text] [Related]
58. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.
Dimitroulis D; Damaskos C; Valsami S; Davakis S; Garmpis N; Spartalis E; Athanasiou A; Moris D; Sakellariou S; Kykalos S; Tsourouflis G; Garmpi A; Delladetsima I; Kontzoglou K; Kouraklis G
World J Gastroenterol; 2017 Aug; 23(29):5282-5294. PubMed ID: 28839428
[TBL] [Abstract][Full Text] [Related]
59. [Hepatitis DNA viruses and their correlation to hepatocellular cancer].
Roggendorf M
Internist (Berl); 1985 Oct; 26(10):621-7. PubMed ID: 3000972
[No Abstract] [Full Text] [Related]
60. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
Kohli A
Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
